Navigation Links
ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
Date:9/16/2010

ndomized at a ratio of 1:1:1 to receive either bromfenac or placebo in both eyes twice daily and will be evaluated over the course of 42 days.  For both efficacy studies, the objective sign of conjunctival staining will be measured using the Lissamine Green test and subjective symptoms will be measured using the Ocular Surface Disease Index (OSDI). ISTA anticipates reporting results in the middle of 2011.  

The two remaining Phase 3 safety studies are the subject of additional SPAs currently under review by the FDA. To meet FDA guidance on drugs for chronic dosing, the Company expects to conduct both a six-month and a twelve-month safety study. ISTA anticipates it will initiate one or both of these safety studies later this year, subject to reaching agreement with the FDA on the SPAs.

ABOUT DRY EYE DISEASE

Dry eye occurs when there is an imbalance of tears that provides moisture and lubrication to the eye, which can result in pain, itching, redness, blurry vision, light sensitivity and/or a gritty sensation or feeling of sand in the eye.  Causes for dry eye include environmental conditions such as air conditioning, smoke and dust, aging and menopause, side-effects from antihistamines and birth control pills, Sjogren's syndrome, rheumatoid arthritis and structural problems with the eye lid's ability to close. Left untreated, dry eye can lead to abrasions on the surface of the eye and damage to the cornea. Current treatments include artificial tears and ointments, topical steroids, a topical immunomodulator that is the only approved prescription eye drop treatment and punctal occlusion (closing or plugging of tear drains).  

ABOUT BROMFENAC OPHTHALMIC SOLUTION

REMURA (bromfenac ophthalmic solution for dry eye) is a sterile, topical non-steroidal anti-inflammatory (NSAID) compound under investigation for use as an ophthalmic agent to alleviate the signs and symptoms of dry eye disease. Since 2
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
4. Access Pharmaceuticals Launches MuGard Product Website
5. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
6. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
7. ARCADIS Jane Staveley to Moderate Congressional Briefing on Pharmaceuticals in Drinking Water
8. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
9. Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 22. Mai 2013 Ranbaxy ... Tochtergesellschaft von Daiichi Sankyo Co., Ltd. ... 22. Mai die Maßnahmen bekannt, die ... hat, um sich der Angelegenheiten der ... http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi Sankyo ...
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... May 22, 2013  Team Health Holdings Inc. ("TeamHealth") ... suppliers of outsourced healthcare professional staffing and administrative services ... the United States , today announced that its ... Bank Healthcare Conference held on May 29, 2013 at ... 8:00 AM eastern time.  Interested investors and other parties ...
Breaking Medicine Technology:Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... THE WOODLANDS, Texas , Jan. 25 In response ... York Times article, " Radiation Offers New Cures and Ways to ... patients and the general public understand that the benefits received from radiation therapy ... disease with help from the US Oncology physician network, and their loved ones, ...
... , , , MOUNTAIN VIEW, Calif. ... enrollment of its pivotal US study for the ArterX Vascular ... patients who were scheduled to receive a synthetic vascular graft ... applications involved the placement of arteriovenous dialysis access grafts, carotid ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2
(Date:5/23/2013)... Better Life Maids of Portland Oregon is putting on ... one of a kind green house cleaning service in the ... May 29th, and a soft opening scheduled for June 3rd, ... in Portland recently and will travel to St. Louis June ... really is a lot to take in" stated Heather Richardson. ...
(Date:5/23/2013)... 23, 2013 Footwear etc. is pleased to ... Collection of sandals containing cork footbeds. Known for its extremely ... good sales for many years, and with this new collection ... , Dansko Shoes and Sandals are renowned ... is no exception. Containing leather and patent leather uppers in ...
(Date:5/23/2013)... Long-Term Care Insurance shopping site LTC Tree has ... for Long Term Care Insurance are approved by insurance companies ... to buy a Long Term Care Insurance policy is an ... purchase protection are increasingly being turned away by insurance companies, ... variety of chronic conditions appear to be responsible for the ...
(Date:5/23/2013)... AttorneyOne.com, a recognized authority on law, ... providing expert opinion in view of the recent news ... to court documents, on March 5, 2013 a woman ... no. 3:2013cv50102) alleging that her husband suffered massive brain ... is mainly used as a blood thinner for patients ...
(Date:5/22/2013)... St. Petersburg, FL (PRWEB) May 23, 2013 ... rarely affects men due to several factors, including estrogen ... Cellulite is essentially toxins and fatty deposits stored and ... skin. "To diminish cellulite, one must take a multi-pronged ... These multi-pronged actions include: , Specific products like ...
Breaking Medicine News(10 mins):Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2
... H1N1 in a cat or pigs are likely very rare, experts ... news broke on Wednesday that a domestic cat had come down ... owners, many people no doubt wondered how vulnerable their own pets ... protecting from this strain of flu? The answer, experts say, is ...
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ) ... results for the quarter ending September 30, 2009, and ... 4:30 p.m. Eastern Time on Thursday, November 12, 2009. ... Jana Ahlfinger Bell, executive vice president and chief financial ...
... , PURCHASE, N.Y., Nov. 4 Nutrition 21, Inc. ... ingredients and finished products under the Iceland Health®, Chromax®, ... sugar levels, improve cardiovascular health, enhance memory and reduce ... first quarter of fiscal year 2010 ended September 30, ...
... differently than Gardasil, Cervarix, it targets inside of virus, ... A vaccine that targets human papillomavirus (HPV) is able ... into full-blown malignancies, Dutch researchers report. , Two other ... for young women to prevent infection with HPV, which ...
... Inc. (Nasdaq: GHDX ) today reported financial results and business ... increased to $39.5 million in the third quarter of 2009 compared ... revenue from the Onco type DX® breast cancer test was ... 39 percent, compared with $28.1 million in the third quarter of ...
... Nov. 4 (HealthDay News) -- Eating too fast can lead ... hormones in the gut that trigger the feeling of being ... ate 300 milliliters of ice cream at different rates. Blood ... before and after consumption of the ice cream. Participants who ...
Cached Medicine News:Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 2Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 3Health News:EF Johnson Technologies, Inc. Announces Third Quarter Financial Reporting Date 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 3Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 4Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 5Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 6Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 2Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 2Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 4Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 5Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 6Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 7Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 8Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 9Health News:Fast Eating Limits Gut Hormones That Induce Fullness 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: